Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (7)

1

Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States : incorporating longer survival results

enthalten in: Journal of medical economics | 2024

von Oluwole, O. | Ray, M. | Davies, N. | +4

2

Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma

enthalten in: Transplantation and cellular therapy | 2023

von Ahmed, N. | Wesson, W. | Mushtaq, M. | +16

3

Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas

enthalten in: Transplantation and cellular therapy | 2022

von Riedell, P. | Hwang, W. | Nastoupil, L. | +15

CommentIn: Transplant Cell Ther. 2022 Oct;28(10):621-622. - PMID 36202524

4

Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States

enthalten in: Journal of medical economics | 2021

von Liu, R. | Oluwole, O. | Diakite, I. | +3

5

Response to Letter to Editor Regarding "Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma"

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2020

von Oluwole, O. | Jansen, J. | Lin, V. | +4

CommentOn: Biol Blood Marrow Transplant. 2020 Sep;26(9):1581-1588. - PMID 32561336

6

Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2020

von Oluwole, O. | Jansen, J. | Lin, V. | +4

CommentIn: Biol Blood Marrow Transplant. 2020 Dec;26(12):e335-e336. - PMID 32950694

7

Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019

von Byrne, M. | Oluwole, O. | Savani, B. | +3

1
[1]